PLCG1 and Alzheimer disease: FLX, imipramine, KET, and R,R-HNK increased TRKB interaction with PLC-γ1 and their effects were blocked by βCDX (Figures 1C and S1N–S1Q), which indicates that CHOL modulates AD-induced TRKB signaling.